Tag: vascular trauma
SVS Women’s Section delves into vascular trauma treatment intricacies amid ‘paucity...
“Life over limb”—that was one of the key messages to emerge from the VAM 2024 SVS Women’s Section session that placed a lens over...
Women’s Section to place a lens over vascular trauma
The SVS Women's Section will host their VAM 2024 session, “Vascular Trauma: What I Need to Know in the Middle of the Night” at...
Pediatric vascular trauma: ‘Collaboration really matters in this space’
The focus of yesterday’s American Pediatric Surgical Association (APSA)-SVS task force’s spring quarterly interest group meeting at VAM 2024 was the “incredibly crucial” topic...
Pediatric vascular care in focus: Raising awareness of supportive care processes
In 2021, the Society for Vascular Surgery (SVS) and the American Pediatric Surgical Association (APSA) established a task force dedicated to optimizing pediatric vascular...
Humacyte submits Biologics License Application to FDA seeking approval of Human...
Humacyte today announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) seeking approval of the Human...
SVS webinar covers insights learned from experiences of mass-casualty disasters
A mass shooting in Las Vegas. A bombing at the finish line of the Boston Marathon. A shooting at a Fourth of July parade....
MVSS 2023: Human Acellular Vessel proves ‘safe, effective bypass conduit’ in...
An investigator-sponsored clinical study conducted at the Mayo Clinic in Rochester, Minnesota, of the investigational Human Acellular Vessel (HAV) in patients with chronic limb-threatening...
Humacyte announces positive top line results from Phase 2/3 trial of...
Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.
A...
Clinical performance of Human Acellular Vessel amid war in Ukraine presented...
Clinical outcomes of Humacyte's investigational Human Acellular Vessel (HAV) were presented at the Military Health System Research Symposium in Kissimmee, Florida (Aug. 14–17), following...
Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel...
Humacyte today announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA)...
VAM 2023: Vascular trauma session to highlight the current role of...
A focused session on vascular trauma yesterday took a deep dive into emerging issues and controversies in the field.
Moderated by Sherene Shalhub, MD, of...
Sudanese vascular association readies for first-ever conference
The Sudanese Association of Vascular Surgeons (SudAVaS) has announced the scientific program behind its first-ever international conference, marking the occasion by celebrating the “first...
Human-tissue engineered blood vessels remain durable at six years in PAD...
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72...
Veterans Day: Remembering Korea, ‘accidental pioneers’ and M*A*S*H
During November—Nov. 11, specifically—the United States salutes and honors all those who have served this country in its armed forces. This November, the Society...
An open letter to the National Rifle Association
Hello,
I think it is time we talked about guns. I know you don’t like to discuss these things after a school shooting, so I...
A recent snapshot of pediatric vascular trauma injuries
A study of major pediatric vascular injuries delivered in the Vascular and Endovascular Surgery Society (VESS) Paper Session during the 2022 Vascular Annual Meeting...
The top 10 most popular Vascular Specialist stories of August 2022
The top 10 most-read stories on the Vascular Specialist website in August included a look at the state of diversity, equity and inclusion (DEI)...
Confessions of a dual-trained, dual-practicing vascular-trauma surgeon
Like most of the other readers of Vascular Specialist, I look forward to perusing each release for not just useful information but also insightful...
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury...
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients...
Humacyte provides update on patients treated at front-line hospitals in Ukraine...
Humacyte today announced that the first Ukrainian patients have received implants of the Human Acellular Vessel (HAV) for the treatment of vascular trauma injuries....
The top 10 most popular Vascular Specialist stories in May 2022
News on the Society for Vascular Surgery (SVS) ballots set to determine the next vice president and secretary, a hard-hitting column about vascular surgery's...
A modest proposal: Let’s eat the trauma surgeons
Well folks, after more than two years of the pandemic, racial injustice, and medical misinformation, I have decided it is time to return to...
War in Ukraine: A tale of unspeakable horror, unprecedented unity and...
This editorial was written in the days leading up to April 2.
At about 4 a.m. (Kyiv time) on Feb. 24, Russian President Vladimir Putin...
SVS members receive deep discount on key textbooks
Society for Vascular Surgery (SVS) members receive many important discounts as a privilege of belonging. These perks include discounts to important references in diagnosing...
New data add to body of evidence highlighting ‘importance’ of vascular...
Another study has emerged showing vascular surgery’s heavy intraoperative consult activity in a level 1 trauma center setting, lending further fuel to the “vascular...
Vascular Specialist–February 2022
In this issue:
"Vital signs": Reporting from the Southern Association for Vascular Surgery (SAVS) annual meeting on skyrocketing nursing costs and their contribution to...
Intravascular shunts improve early limb salvage after extremity vascular injury, study...
A multicenter retrospective study of the PROOVIT (Prospective observational vascular injury treatment) registry suggests the use of temporary intravascular shunts (TIVSs) results in lower...
Treo IDE primary endpoint results announced
In the wake of approval by the Food and Drug Administration (FDA) of the Treo abdominal aortic stent-graft system for the treatment of patients...
Upper-extremity vascular injuries associated with ‘increased prevalence’ of nerve deficits
Vascular injuries of the upper extremity are associated with a lower rate of limb loss but have an increased prevalence of nerve deficits after...
Correct billing in severe trauma cases can be complicated
The management of the severely injured trauma patient often requires delicate coordination among multiple specialties, and multiple separate operative procedures are often necessary. In...
‘Alea iacta est’: The case for endovascular methods in vascular trauma...
When Benjamin W. Starnes, MD, talks vascular trauma, he does so from a position of certain authority. As the recent Southern California Vascular Surgical...
Vietnam War-era vascular trauma pioneer honored by department he founded
During a storied career, Norman M. Rich, MD, carved out a reputation as a pioneering vascular surgeon—drawing distinction for the creation of the Vietnam...
Claim emerging vascular surgeons ‘less well prepared to rapidly achieve open...
A recent perspective published in the Annals of Surgery—which argued the shift toward endovascular care had led to a deficit in open surgical experience...